An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline

Antzeko izenburuak

• Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects
  nork: Sun, Haiying, et al.
  Argitaratua: (2016)
• Correction for Kovacs et al., “An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline”
  nork: Kovacs, Steven J., et al.
  Argitaratua: (2020)
• Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of (14)C-Omadacycline in Rats
  nork: Lin, Wen, et al.
  Argitaratua: (2016)
• Phase I, Open-Label, Single-Dose Study To Evaluate the Pharmacokinetics and Safety of Telbivudine in Children and Adolescents with Chronic Hepatitis B
  nork: Stein, Daniel S., et al.
  Argitaratua: (2013)
• Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline
  nork: Rodvold, Keith A, et al.
  Argitaratua: (2019)